Physical properties of ordered mesoporous SBA-15 silica as immunological adjuvant

被引:22
作者
Mariano-Neto, F. [1 ]
Matos, J. R. [3 ]
Cides da Silva, L. C. [3 ]
Carvalho, L. V. [2 ]
Scaramuzzi, K. [2 ]
Sant'Anna, O. A. [2 ]
Oliveira, C. P. [1 ]
Fantini, M. C. A. [1 ]
机构
[1] Univ Sao Paulo, Inst Fis, BR-05314970 Sao Paulo, Brazil
[2] Inst Butantan, BR-05503900 Sao Paulo, Brazil
[3] Univ Sao Paulo, Inst Quim, BR-05314970 Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
mesoporous silica; adjuvant; immune response; SAXS; DRUG-DELIVERY; NANOPARTICLES; ADSORPTION; PARAMETERS;
D O I
10.1088/0022-3727/47/42/425402
中图分类号
O59 [应用物理学];
学科分类号
摘要
This work reports a detailed analysis of the ordered mesoporous SBA-15 silica synthesis procedure that provides a matrix with mean pore diameter around 10 nm. The encapsulation of bovine serum albumin (BSA) by four different methods allowed the determination of the best imbibition condition, which is keeping the mixture under rest and solvent evaporation. Simulation of the in situ SAXS scattered intensity of the BSA release in potassium buffer solution, gastrointestinal fluids revealed a slow evolution of BSA content, independent of the media. Proton induced x-ray emission results obtained in calcined mouse organs revealed that silica is only present in the spleen after 35 days and is completely eliminated from all mouse organs after 10 weeks. Biological studies showed that Santa Barbara Amorphous-15 is an effective adjuvant when compared to the traditional Al(OH)(3), and is non-toxic to mice, rats, dogs and even cells, such as macrophages and dendritic cells. Recent studies showed that the immunological response is improved by enhancing the inflammatory response and the recruitment of immune competent cells to the site of injection as by the oral route and, most importantly, by increasing the number of phagocytes of a particulate antigen by antigen presenting cells.
引用
收藏
页数:10
相关论文
共 29 条
[1]   Use of SBA-15 for furosemide oral delivery enhancement [J].
Ambrogi, Valeria ;
Perioli, Luana ;
Pagano, Cinzia ;
Marmottini, Fabio ;
Ricci, Maurizio ;
Sagnella, Anna ;
Rossi, Carlo .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 46 (1-2) :43-48
[2]  
[Anonymous], 2007, International Patent, Patent No. [WO 07030901, 07030901]
[3]   THE DETERMINATION OF PORE VOLUME AND AREA DISTRIBUTIONS IN POROUS SUBSTANCES .1. COMPUTATIONS FROM NITROGEN ISOTHERMS [J].
BARRETT, EP ;
JOYNER, LG ;
HALENDA, PP .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1951, 73 (01) :373-380
[4]   Adsorption of gases in multimolecular layers [J].
Brunauer, S ;
Emmett, PH ;
Teller, E .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1938, 60 :309-319
[5]   Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15 [J].
Carvalho, Luciana V. ;
Ruiz, Rita de C. ;
Scaramuzzi, Karina ;
Marengo, Eliana B. ;
Matos, Jivaldo R. ;
Tambourgi, Denise V. ;
Fantini, Marcia C. A. ;
Sant'Anna, Osvaldo A. .
VACCINE, 2010, 28 (50) :7829-7836
[6]   Inclusion of ibuprofen in mesoporous templated silica:: drug loading and release property [J].
Charnay, C ;
Bégu, S ;
Tourné-Péteilh, C ;
Nicole, L ;
Lerner, DA ;
Devoisselle, JM .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (03) :533-540
[7]   SBA-15-collagen hybrid material for drug delivery applications [J].
Fagundes, L. B. ;
Sousa, T. G. F. ;
Sousa, A. ;
Silva, V. V. ;
Sousa, E. M. B. .
JOURNAL OF NON-CRYSTALLINE SOLIDS, 2006, 352 (32-35) :3496-3501
[8]   In vivo Biodistribution and Urinary Excretion of Mesoporous Silica Nanoparticles: Effects of Particle Size and PEGylation [J].
He, Qianjun ;
Zhang, Zhiwen ;
Gao, Fang ;
Li, Yaping ;
Shi, Jianlin .
SMALL, 2011, 7 (02) :271-280
[9]   The biocompatibility of mesoporous silicates [J].
Hudson, Sarah P. ;
Padera, Robert F. ;
Langer, Robert ;
Kohane, Daniel S. .
BIOMATERIALS, 2008, 29 (30) :4045-4055
[10]   In vitro stability of SBA-15 under physiological conditions [J].
Izquierdo-Barba, I. ;
Colilla, M. ;
Manzano, M. ;
Vallet-Regi, M. .
MICROPOROUS AND MESOPOROUS MATERIALS, 2010, 132 (03) :442-452